4.46MMarket Cap-474P/E (TTM)
0.497High0.460Low24.77KVolume0.481Open0.494Pre Close11.98KTurnover24.89%Turnover RatioLossP/E (Static)9.67MShares10.08052wk High0.39P/B45.87KFloat Cap0.45252wk Low--Dividend TTM99.50KShs Float595.826Historical High--Div YieldTTM7.40%Amplitude0.452Historical Low0.483Avg Price1Lot Size
Notable Labs Stock Forum
Notable Labs, Ltd. (Nasdaq: NTBL) has recently announced a pivotal development in its clinical-stage journey. The company, known for its innovative Predictive Medicine Platform (PMP), disclosed that it has received the coveted "Clearance to Proceed" from the FDA for its Phase 2 volasertib program. A crucial step forward in th...
Notable Labs Receives FDA Clearance to Proceed Further with Volasertib Phase 2 Study
Wednesday, 24th July at 7:30 am
FOSTER CITY, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (NASDAQ: NTBL) ("Notable", "Notable Labs" or the "Company"), a clinical-stage precision oncology company developing new cancer therapies identified by its Predictive Medicine Platform (PMP), today announced progress for the Phase 2 volasertib program following receipt of "Clearance to...
Notable Labs Receives FDA Clearance to Proceed Further With Volasertib Phase 2 Study
Up to 19,736,842 Ordinary Shares or Pre-Funded Warrants to Purchase Ordinary Shares
Ordinary Warrants to Purchase Up to 19,736,842 Ordinary Shares
Up to 39,473,684 Ordinary Shares Underlying the Ordinary Warrants and Pre-Funded Warrants
No comment yet